MI
JANX icon

Markowski Investments’s Janux Therapeutics JANX Stock Holding History

Markowski Investments’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.68K Buy
+500
New +$7.24K ﹤0.01% 432

Other funds holding JANX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AG
Algert Global San Francisco, California $8.43B AUM 80.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return

Markowski Investments's JANX Position: Q2 2026 in Review

Markowski Investments opened a new position in Janux Therapeutics (JANX) in Q2 2026: 500 shares worth $7.68K. The stake represents ﹤0.01% of the portfolio and ranks #432 among its holdings.

124 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Markowski Investments held 500 shares of Janux Therapeutics worth $7.68K as of Q2 2026.
  • Janux Therapeutics was a new Markowski Investments position in Q2 2026.
  • Janux Therapeutics made up ﹤0.01% of Markowski Investments's portfolio in Q2 2026, its #432 holding.
  • 124 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Markowski Investments's 13F filing for Q2 2026, filed 13 Aug 2026.